RATIONALE: Chitinases are enzymes that cleave chitin, which is present in fungal cells. Two types of human chitinases, chitotriosidase and acidic mammalian chitinase, and the chitinase-like protein, YKL-40, seem to play an important role in asthma. We hypothesized that exposure to environmental fungi may modulate the effect of chitinases in individuals with asthma. OBJECTIVES: To explore whether interactions between high fungal exposure and common genetic variants in the two chitinases in humans, CHIT1 and CHIA, and the chitinase 3-like 1 gene, CHI3L1, are associated with severe asthma exacerbations and other asthma-related outcomes. METHODS: Forty-eight single nucleotide polymorphisms (SNPs) in CHIT1, CHIA, and CHI3L1 and one CHIT1 duplication were genotyped in 395 subjects and their parents as part of the Childhood Asthma Management Program. Household levels of mold (an index of fungal exposure) were determined on house dust samples. We conducted family-based association tests with gene-environment interactions. Our outcome was severe exacerbation, defined as emergency department visits and hospitalizations from asthma over a 4-year period, and our secondary outcomes included indices of lung function and allergy-related phenotypes. MEASUREMENTS AND MAIN RESULTS: Of the 395 subjects who had mold levels at randomization, 24% (95 subjects) had levels that were greater than 25,000 units per gram of house dust (high mold exposure). High mold exposure significantly modified the relation between three SNPs in CHIT1 (rs2486953, rs4950936, and rs1417149) and severe exacerbations (P for interaction 0.0010 for rs2486953, 0.0008 for rs4950936, and 0.0005 for rs1417149). High mold exposure did not significantly modify the relationship between any of the other variants and outcomes. CONCLUSIONS: Environmental exposure to fungi, modifies the effect of CHIT1 SNPs on severe asthma exacerbations.
RATIONALE: Chitinases are enzymes that cleave chitin, which is present in fungal cells. Two types of human chitinases, chitotriosidase and acidic mammalian chitinase, and the chitinase-like protein, YKL-40, seem to play an important role in asthma. We hypothesized that exposure to environmental fungi may modulate the effect of chitinases in individuals with asthma. OBJECTIVES: To explore whether interactions between high fungal exposure and common genetic variants in the two chitinases in humans, CHIT1 and CHIA, and the chitinase 3-like 1 gene, CHI3L1, are associated with severe asthma exacerbations and other asthma-related outcomes. METHODS: Forty-eight single nucleotide polymorphisms (SNPs) in CHIT1, CHIA, and CHI3L1 and one CHIT1 duplication were genotyped in 395 subjects and their parents as part of the Childhood Asthma Management Program. Household levels of mold (an index of fungal exposure) were determined on house dust samples. We conducted family-based association tests with gene-environment interactions. Our outcome was severe exacerbation, defined as emergency department visits and hospitalizations from asthma over a 4-year period, and our secondary outcomes included indices of lung function and allergy-related phenotypes. MEASUREMENTS AND MAIN RESULTS: Of the 395 subjects who had mold levels at randomization, 24% (95 subjects) had levels that were greater than 25,000 units per gram of house dust (high mold exposure). High mold exposure significantly modified the relation between three SNPs in CHIT1 (rs2486953, rs4950936, and rs1417149) and severe exacerbations (P for interaction 0.0010 for rs2486953, 0.0008 for rs4950936, and 0.0005 for rs1417149). High mold exposure did not significantly modify the relationship between any of the other variants and outcomes. CONCLUSIONS: Environmental exposure to fungi, modifies the effect of CHIT1 SNPs on severe asthma exacerbations.
Authors: Edmund J S Sonuga-Barke; Jessica Lasky-Su; Benjamin M Neale; Robert Oades; Wai Chen; Barbara Franke; Jan Buitelaar; Tobias Banaschewski; Richard Ebstein; Michael Gill; Richard Anney; Ana Miranda; Fernando Mulas; Herbert Roeyers; Aribert Rothenberger; Joseph Sergeant; Hans Christoph Steinhausen; Margaret Thompson; Philip Asherson; Stephen V Faraone Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-12-05 Impact factor: 3.568
Authors: Sibylle Bierbaum; Renate Nickel; Anja Koch; Susanne Lau; Klaus A Deichmann; Ulrich Wahn; Andrea Superti-Furga; Andrea Heinzmann Journal: Am J Respir Crit Care Med Date: 2005-09-22 Impact factor: 21.405
Authors: D Gautrin; A Cartier; D Howse; L Horth-Susin; M Jong; M Swanson; S Lehrer; G Fox; B Neis Journal: Occup Environ Med Date: 2009-09-06 Impact factor: 4.402
Authors: Tiffany A Reese; Hong-Erh Liang; Andrew M Tager; Andrew D Luster; Nico Van Rooijen; David Voehringer; Richard M Locksley Journal: Nature Date: 2007-04-22 Impact factor: 49.962
Authors: Jaleesa M Garth; Joseph J Mackel; Kristen M Reeder; Jonathan P Blackburn; Chad W Dunaway; Zhihong Yu; Sadis Matalon; Lori Fitz; Chad Steele Journal: Infect Immun Date: 2018-06-21 Impact factor: 3.441